Free tool
Healthcare stocks
We cover 994 companies in the Healthcare sector. The median market value in the group is $37.62M. Across the group, the median move over the past trading day is −0.04%. 40% of the 969 with a 200-day average trade above it. Price change over the past year runs from −79.2% to +80.8% across the middle 80 percent of the group, with a median of −17.9%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
Table
994 of 2,203 companies match these filters.Clear filters
| Ticker | Company | Price | 1M return | YTD return | 1Y return |
|---|---|---|---|---|---|
| LILY34.SA | Eli Lilly and Company | 211.20 BRL | +0.76% | +9.59% | +59.83% |
| LLY.DE | Eli Lilly and Company | 1,080.40 EUR | +0.43% | +19.60% | +73.55% |
| LLY | Eli Lilly and Company | $1,189.41 | −2.56% | +10.47% | +62.80% |
| JNJ | Johnson & Johnson | $270.00 | +1.23% | +31.66% | +55.40% |
| JNJB34.SA | Johnson & Johnson | 92.80 BRL | +2.16% | +24.99% | +47.82% |
| JNJ.DE | Johnson & Johnson | 234.20 EUR | −0.62% | +34.82% | +58.93% |
| 4AB.DE | AbbVie Inc. | 228.40 EUR | −2.56% | +19.14% | +32.34% |
| ABBV | AbbVie Inc. | $262.90 | −0.11% | +16.53% | +29.36% |
| ABBV34.SA | AbbVie Inc. | 84.88 BRL | −0.29% | +9.50% | +21.88% |
| RHO.DE | Roche Holding AG | 405.40 EUR | +2.01% | +14.00% | +41.42% |
| N1VS34.SA | Novartis AG | 81.76 BRL | +1.49% | +11.09% | +20.04% |
| NOT.DE | Novartis AG | 136.70 EUR | −1.56% | +19.69% | +28.89% |
| NVS | Novartis AG | $157.54 | −1.45% | +17.18% | +27.93% |
| AZN.L | AstraZeneca PLC | 12,476.00 GBP | −5.00% | −8.20% | +5.65% |
| AZN | AstraZeneca PLC | $166.27 | −3.60% | −8.27% | +5.09% |
| A1ZN34.SA | AstraZeneca PLC | 143.10 BRL | −2.15% | −13.50% | +0.13% |
| AZN.ST | AstraZeneca PLC | 1,609.00 SEK | −4.94% | −4.94% | +6.22% |
| TN8.DE | Thermo Fisher Scientific Inc. | 537.00 EUR | +5.63% | +6.86% | +29.67% |
| NVO.WA | Novo Nordisk A/S | 175.12 PLN | −10.34% | −1.45% | −9.22% |
| NOVO-B.CO | Novo Nordisk A/S | 307.80 DKK | −8.95% | −3.58% | −11.26% |
| NOV.DE | Novo Nordisk A/S | 41.42 EUR | −8.48% | +24.38% | +15.22% |
| N1VO34.SA | Novo Nordisk A/S | 30.41 BRL | −6.72% | −12.87% | −17.86% |
| NVO | Novo Nordisk A/S | $47.19 | −7.40% | −6.62% | −13.32% |
| ABL.DE | Abbott Laboratories | 98.74 EUR | +2.64% | −5.19% | −10.02% |
| PODD | Insulet Corporation | $143.38 | −14.38% | −49.32% | −57.12% |
| AVTR | Avantor, Inc. | $14.50 | +16.75% | +26.53% | +9.93% |
| PTGX | Protagonist Therapeutics, Inc. | $151.50 | +10.71% | +73.78% | +146.62% |
| NUVL | Nuvalent Inc | $123.96 | 0.00% | +22.93% | +62.83% |
| OSCR | Oscar Health, Inc. | $31.24 | −0.51% | +108.68% | +83.55% |
| TWST | Twist Bioscience Corporation | $150.06 | +69.46% | +363.29% | +451.89% |
| DEMANT.CO | Demant A/S | 284.60 DKK | +0.21% | +33.36% | +17.12% |
| WDH1.DE | Demant A/S | 39.10 EUR | +2.84% | +36.62% | −5.53% |
| KRK.WA | Krka, d. d. | 1,110.00 PLN | −2.63% | +29.07% | +30.59% |
| PCVX | Vaxcyte, Inc. | $61.09 | +11.89% | +31.49% | +99.97% |
| IMVT | Immunovant, Inc. | $43.89 | +12.83% | +69.39% | +189.13% |
| QGEN | Qiagen N.V. | $43.36 | +2.55% | −4.05% | −9.65% |
| QIA.DE | Qiagen N.V. | 36.71 EUR | −0.60% | −3.76% | −6.73% |
| HQY | HealthEquity, Inc. | $104.42 | +3.14% | +14.66% | +18.69% |
| BRKR | Bruker Corporation | $57.06 | −9.30% | +18.78% | +70.56% |
| ATR | AptarGroup, Inc. | $135.24 | −1.52% | +11.23% | −1.89% |
| 4151.T | Kyowa Kirin Co., Ltd. | 2,613.00 JPY | −3.33% | +3.94% | +4.01% |
| 4523.T | Eisai Co., Ltd. | 4,792.00 JPY | −6.22% | +1.75% | +7.64% |
| TGTX | TG Therapeutics, Inc. Common Stock | $55.03 | +0.29% | +87.94% | +92.61% |
| ALKS | Alkermes plc | $49.16 | −2.65% | +73.96% | +68.07% |
| SYRE | Spyre Therapeutics, Inc. | $93.61 | −6.36% | +206.10% | +446.12% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $111.87 | +3.54% | +6.53% | +9.35% |
| 2413.T | M3, Inc. | 1,796.00 JPY | −9.48% | −12.15% | −17.22% |
| 4528.T | Ono Pharmaceutical Co., Ltd. | 2,462.50 JPY | −1.16% | +14.31% | +54.43% |
| SRRK | Scholar Rock Holding Corporation | $60.04 | +21.61% | +40.28% | +74.18% |
| 6869.T | Sysmex Corporation | 1,915.50 JPY | +14.53% | +26.54% | +3.66% |
| ALK-B.CO | ALK-Abelló A/S | 208.80 DKK | −6.62% | −7.16% | +5.09% |
| HNGE | Hinge Health, Inc. | $90.50 | +20.27% | +98.64% | +56.66% |
| SHL.AX | Sonic Healthcare Limited | 20.12 AUD | −11.44% | −8.60% | −11.84% |
| CHE | Chemed Corporation | $548.56 | +5.98% | +29.61% | +20.79% |
| PACS | PACS Group, Inc. | $44.39 | −5.47% | +12.35% | +274.28% |
| GETI-B.ST | Getinge AB (publ) | 243.30 SEK | +2.18% | +14.56% | +20.89% |
| HIMS | Hims & Hers Health, Inc. | $29.83 | +1.74% | −10.72% | −32.22% |
| CGON | CG Oncology, Inc. | $78.42 | +7.99% | +87.65% | +196.15% |
| 3391.T | Tsuruha Holdings Inc. | 2,379.00 JPY | −8.08% | −16.55% | +5.97% |
| 0126Z0.KS | SAMSUNG EPIS HOLDINGS | 387,000.00 KRW | +9.79% | −45.87% | +15.35% |
| ERAS | Erasca, Inc. | $19.15 | +5.45% | +433.43% | +1112.03% |
| 7747.T | Asahi Intecc Co., Ltd. | 3,876.00 JPY | +4.76% | +30.59% | +53.99% |
| E2XE34.SA | Exelixis, Inc. | 137.40 BRL | −2.25% | +23.92% | +23.92% |
| LNTH | Lantheus Holdings, Inc. | $100.82 | −1.77% | +49.87% | +77.38% |
| ORKA | Oruka Therapeutics, Inc. | $99.44 | +9.94% | +251.75% | +555.07% |
| RADL3.SA | Raia Drogasil S.A. | 19.31 BRL | +6.10% | −18.17% | +7.42% |
| HLUN-B.CO | H. Lundbeck A/S | 42.68 DKK | +1.19% | +2.35% | +8.99% |
| 3088.T | MatsukiyoCocokara & Co. | 2,575.00 JPY | −4.35% | −4.12% | −14.74% |
| COH.AX | Cochlear Limited | 136.01 AUD | +11.03% | −47.23% | −53.79% |
| COGT | Cogent Biosciences, Inc. | $36.72 | −9.71% | +5.70% | +196.85% |
| BLTE | Belite Bio, Inc | $156.69 | +0.47% | −1.62% | +144.07% |
| LQDA | Liquidia Corporation | $71.36 | −17.81% | +127.26% | +154.86% |
| AMRX | Amneal Pharmaceuticals, Inc. | $17.99 | −4.10% | +42.10% | +92.20% |
| TVTX | Travere Therapeutics, Inc. | $67.12 | +20.05% | +69.84% | +284.86% |
| XENE | Xenon Pharmaceuticals Inc. | $63.79 | −1.77% | +43.38% | +64.11% |
| BLCO.TO | Bausch + Lomb Corporation | 24.00 CAD | +2.61% | +5.31% | +19.34% |
| BLCO | Bausch + Lomb Corporation | $17.25 | +3.85% | +4.04% | +18.56% |
| DNTH | Dianthus Therapeutics, Inc. | $110.76 | +9.01% | +179.13% | +356.93% |
| STVN | Stevanato Group S.p.A. | $22.38 | +11.07% | +8.75% | −0.09% |
| PTCT | PTC Therapeutics, Inc. Common Stock | $72.69 | −3.58% | −5.28% | +46.02% |
| KNSA | Kiniksa Pharmaceuticals International, plc | $78.68 | −0.96% | +87.31% | +133.47% |
| RDNT | RadNet, Inc. | $76.47 | +20.96% | +7.78% | +7.27% |
| CTEC.L | Convatec Group PLC | 228.80 GBP | −0.78% | −4.49% | −1.95% |
| T1FX34.SA | Teleflex Incorporated | 69.78 BRL | 0.00% | +3.04% | +0.29% |
| MIRM | Mirum Pharmaceuticals, Inc. | $98.51 | −12.22% | +26.18% | +31.96% |
| DFTX | Definium Therapeutics, Inc. | $43.77 | +4.31% | +220.89% | +344.37% |
| TFX | Teleflex Incorporated | $138.74 | +3.38% | +13.97% | +8.06% |
| LGND | Ligand Pharmaceuticals Incorporated | $287.85 | −2.85% | +51.41% | +80.92% |
| CRSP | CRISPR Therapeutics AG | $59.23 | +24.56% | +10.15% | +10.65% |
| SECT-B.ST | Sectra AB (publ) | 276.20 SEK | −2.47% | +15.28% | −17.02% |
| SHC | Sotera Health Company | $19.54 | +10.02% | +10.46% | +18.42% |
| MMED | MiniMed Group, Inc. | $19.49 | +10.49% | +5.41% | +5.41% |
| MMSI | Merit Medical Systems, Inc. | $90.54 | +15.65% | +4.73% | −0.28% |
| GRFS | Grifols, S.A. | $7.90 | −1.25% | −14.50% | −19.39% |
| ACAD | ACADIA Pharmaceuticals Inc. | $29.58 | +13.73% | +12.51% | +11.33% |
| DYN | Dyne Therapeutics, Inc. | $26.36 | +1.78% | +42.49% | +93.26% |
| 326030.KS | SK Biopharmaceuticals Co., Ltd. | 88,400.00 KRW | +16.93% | −28.07% | −11.24% |
| EWTX | Edgewise Therapeutics, Inc. | $44.38 | +9.99% | +86.86% | +207.13% |
| LFST | LifeStance Health Group, Inc. | $12.15 | +8.10% | +74.57% | +121.31% |
| CELC | Celcuity Inc. | $95.08 | +15.30% | −5.44% | +90.31% |
| WAY | Waystar Holding Corp. | $24.17 | +2.03% | −22.95% | −34.97% |
| 128940.KS | Hanmi Pharm. Co., Ltd. | 503,000.00 KRW | +56.21% | +13.96% | +66.34% |
| HIK.L | Hikma Pharmaceuticals PLC | 1,640.00 GBP | +0.61% | +7.71% | −9.62% |
| BLLN | BillionToOne, Inc. | $96.22 | −28.00% | +7.76% | −11.68% |
| 000100.KS | Yuhan Corporation | 83,100.00 KRW | +18.21% | −25.94% | −27.54% |
| ICUI | ICU Medical, Inc. | $179.59 | +8.33% | +29.64% | +41.83% |
| NVST | Envista Holdings Corporation | $27.80 | +3.12% | +28.17% | +30.89% |
| ELVN | Enliven Therapeutics, Inc. | $60.87 | +13.22% | +291.67% | +194.32% |
| CON | Concentra Group Holdings Parent, Inc. | $34.95 | +6.91% | +81.01% | +50.93% |
| DOCS | Doximity, Inc. | $24.74 | +15.39% | −42.85% | −63.61% |
| LIVN | LivaNova PLC | $79.97 | −2.58% | +31.88% | +41.56% |
| OBCK.DE | Ottobock SE & Co. KGaA | 60.40 EUR | +4.50% | +0.68% | +0.68% |
| MANE | Veradermics, Incorporated | $102.80 | −7.84% | +172.32% | +172.32% |
| TNGX | Tango Therapeutics, Inc. | $25.47 | −4.43% | +185.22% | +269.13% |
| RLAY | Relay Therapeutics, Inc. | $19.46 | +6.40% | +137.90% | +445.10% |
| INDV | Indivior Pharmaceuticals, Inc. | $35.83 | −12.60% | +0.27% | +47.06% |
| ADPT | Adaptive Biotechnologies Corporation | $26.16 | +16.16% | +64.42% | +101.70% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | 23.00 EUR | +3.84% | +58.22% | +1.26% |
| IRTC | iRhythm Holdings, Inc. | $119.15 | +1.52% | −32.00% | −29.83% |
| 4506.T | Sumitomo Pharma Co., Ltd. | 1,436.50 JPY | +13.47% | −41.63% | −3.59% |
| LEGN | Legend Biotech Corporation | $20.68 | +8.61% | −3.86% | −40.44% |
| VKTX | Viking Therapeutics, Inc. | $34.38 | +1.54% | −2.94% | +29.15% |
| DNLI | Denali Therapeutics Inc. | $24.57 | +2.16% | +51.01% | +57.50% |
| RCUS | Arcus Biosciences, Inc. | $30.76 | +13.72% | +32.07% | +191.29% |
| BBZA.DE | BB Biotech AG | 33.40 EUR | 0.00% | +7.22% | +7.22% |
| MCOV-B.ST | Medicover AB (publ) | 243.50 SEK | +8.22% | +14.97% | −8.20% |
| 000105.KS | Yuhan Corporation | 70,500.00 KRW | +19.09% | −30.38% | −32.04% |
| TLX.AX | Telix Pharmaceuticals Limited | 15.68 AUD | +8.14% | +38.03% | +4.88% |
| CAMX.ST | Camurus AB (publ) | 615.00 SEK | −1.68% | +0.49% | −15.35% |
| FIE.DE | Fielmann Group AG | 39.25 EUR | −5.08% | −10.08% | −27.31% |
| TLX | Telix Pharmaceuticals Limited | $11.13 | +9.22% | +46.06% | −8.02% |
| 4536.T | Santen Pharmaceutical Co., Ltd. | 1,851.50 JPY | −8.36% | +13.69% | +21.45% |
| 7459.T | MediPal Holdings Corporation | 2,893.50 JPY | −5.56% | +4.92% | +13.38% |
| IOVA | Iovance Biotherapeutics, Inc. | $8.08 | +71.91% | +220.63% | +233.88% |
| OPCH | Option Care Health, Inc. | $24.04 | +6.94% | −25.43% | −15.91% |
| VCYT | Veracyte, Inc. Common Stock | $44.29 | −20.41% | +4.48% | +54.81% |
| GPCR | Structure Therapeutics Inc. | $49.35 | +3.05% | −27.55% | +159.74% |
| GRAL | GRAIL, Inc. | $79.59 | +23.55% | −10.44% | +136.66% |
| QURE | uniQure N.V. | $50.95 | +38.98% | +117.83% | +223.49% |
| NHC | National HealthCare Corporation | $225.09 | −2.56% | +73.28% | +103.83% |
| 22Z.DE | Zealand Pharma A/S | 43.35 EUR | +7.70% | −29.74% | −28.16% |
| ZEAL.CO | Zealand Pharma A/S | 326.90 DKK | +7.15% | −28.95% | −25.94% |
| IMNM | Immunome, Inc. | $28.75 | +23.82% | +38.09% | +188.94% |
| NAMS | NewAmsterdam Pharma Company N.V. | $27.40 | −2.07% | −22.16% | +11.97% |
| 3349.T | COSMOS Pharmaceutical Corporation | 6,559.00 JPY | −6.35% | −14.64% | −26.59% |
| VIRP.PA | Virbac SA | 329.00 EUR | −5.32% | −6.93% | −2.08% |
| MBX | MBX Biosciences, Inc. | $66.76 | +11.16% | +118.53% | +366.53% |
| BEAM | Beam Therapeutics Inc. | $30.19 | +14.83% | +11.24% | +79.06% |
| AFX.DE | Carl Zeiss Meditec AG | 31.92 EUR | +6.33% | −17.62% | −24.83% |
| TMDX | TransMedics Group, Inc. | $92.22 | +20.88% | −24.83% | −21.43% |
| CLDX | Celldex Therapeutics, Inc. | $40.57 | +14.02% | +50.20% | +79.51% |
| IRON | Disc Medicine, Inc. | $82.67 | +10.74% | +4.53% | +37.90% |
| WRBY | Warby Parker Inc. | $25.48 | −2.00% | +12.64% | −3.96% |
| 7649.T | Sugi Holdings Co.,Ltd. | 2,682.50 JPY | −11.53% | −26.40% | −28.60% |
| ARQT | Arcutis Biotherapeutics, Inc. | $25.14 | −11.54% | −13.31% | +60.64% |
| TARS | Tarsus Pharmaceuticals, Inc. | $70.65 | +19.85% | −12.53% | +22.19% |
| ALMS | Alumis Inc. | $23.62 | −12.62% | +163.76% | +380.08% |
| BIOA-B.ST | BioArctic AB (publ) | 345.00 SEK | +6.35% | +11.66% | +12.31% |
| ASKER.ST | Asker Healthcare Group AB (publ) | 74.70 SEK | −7.15% | −8.74% | −24.65% |
| HYPE3.SA | Hypera S.A. | 22.01 BRL | +2.66% | −4.58% | −4.69% |
| BKD | Brookdale Senior Living Inc. | $12.20 | −20.62% | +12.55% | +55.61% |
| ALHC | Alignment Healthcare, Inc. | $13.90 | −24.58% | −31.26% | −13.88% |
| ACHC | Acadia Healthcare Company, Inc. | $30.58 | −6.45% | +114.00% | +37.81% |
| B72.DE | AtaiBeckley Inc. | 6.45 EUR | +2.38% | +88.27% | +59.69% |
| SLS | SELLAS Life Sciences Group, Inc. | $13.73 | +36.08% | +215.63% | +615.10% |
| NRIX | Nurix Therapeutics, Inc. | $26.71 | +10.60% | +47.90% | +179.69% |
| 9989.T | Sundrug Co.,Ltd. | 3,715.00 JPY | −6.47% | −11.86% | −17.34% |
| VRDN | Viridian Therapeutics, Inc. | $24.26 | +24.35% | −20.93% | +30.71% |
| RGC | Regencell Bioscience Holdings Limited | $5.50 | −7.87% | −73.22% | −61.38% |
| WGS | GeneDx Holdings Corp. | $90.29 | +45.90% | −31.76% | −30.11% |
| AXGN | AxoGen, Inc. Common Stock | $51.58 | +25.35% | +66.39% | +219.58% |
| VERA | Vera Therapeutics, Inc. | $36.82 | +10.50% | −24.27% | +67.21% |
| PGEN | Precigen, Inc. | $7.42 | +34.18% | +73.36% | +61.66% |
| SUPN | Supernus Pharmaceuticals, Inc. | $44.88 | −5.97% | −9.28% | −0.42% |
| RARE | Ultragenyx Pharmaceutical Inc. | $26.44 | +1.77% | +12.03% | −12.10% |
| EBO.AX | EBOS Group Limited | 17.51 AUD | −7.26% | −23.87% | −37.83% |
| PHVS | Pharvaris N.V. | $37.00 | +9.97% | +39.73% | +55.59% |
| BHVN | Biohaven Ltd. | $16.95 | +23.09% | +56.37% | +8.65% |
| TRVI | Trevi Therapeutics, Inc. | $17.92 | −2.77% | +50.71% | +124.00% |
| EMEIS.PA | emeis Société anonyme | 13.80 EUR | −0.86% | −5.61% | +10.93% |
| NEOG | Neogen Corporation | $11.70 | +27.31% | +67.14% | +103.83% |
| 2784.T | Alfresa Holdings Corporation | 2,294.00 JPY | −6.65% | −5.45% | +6.80% |
| NKTR | Nektar Therapeutics | $73.77 | +4.24% | +69.90% | +151.95% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $9.83 | +0.92% | +31.07% | +15.38% |
| CURA.TO | Curaleaf Holdings, Inc. | 13.16 CAD | +8.58% | +267.60% | +197.74% |
| KOD | Kodiak Sciences Inc. | $39.33 | −2.38% | +51.15% | +321.09% |
| PBH | Prestige Consumer Healthcare Inc. | $52.15 | +0.83% | −14.82% | −22.12% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | 111.20 EUR | +15.35% | +66.79% | +70.53% |
| NUVB | Nuvation Bio Inc. | $6.96 | +4.04% | −18.88% | +135.93% |
| 3549.T | Kusuri No Aoki Holdings Co., Ltd. | 4,115.00 JPY | −2.00% | −8.02% | +5.23% |
| BHC | Bausch Health Companies Inc. | $6.51 | +44.03% | −9.71% | −10.45% |
| BHC.TO | Bausch Health Companies Inc. | 9.03 CAD | +41.09% | −8.97% | −9.88% |
| KLRA | Kailera Therapeutics, Inc. | $18.44 | +10.16% | −29.08% | −29.08% |
| OCUL | Ocular Therapeutix, Inc. | $10.77 | +27.46% | −8.88% | −12.58% |
| ALMR | Alamar Biosciences, Inc. | $34.08 | +37.92% | +54.91% | +54.91% |
| GRDN | Guardian Pharmacy Services, Inc. | $37.48 | −10.46% | +26.92% | +45.50% |
| 009420.KS | Hanall Biopharma Co., Ltd. | 64,000.00 KRW | +53.48% | +51.66% | +112.62% |
| UFPT | UFP Technologies, Inc. | $304.57 | +18.02% | +36.33% | +41.94% |
| DMP.DE | Dermapharm Holding SE | 42.00 EUR | −1.98% | +8.95% | +27.27% |
| HRMY | Harmony Biosciences Holdings, Inc. | $39.66 | +10.88% | +6.10% | +4.23% |
| BFLY | Butterfly Network, Inc. | $8.64 | +20.50% | +130.40% | +450.32% |
| COAG | Hemab Therapeutics Holdings, Inc. | $49.19 | +4.08% | +44.68% | +44.68% |
| MLYS | Mineralys Therapeutics, Inc. | $25.89 | −3.93% | −27.50% | +70.22% |
| NEO | NeoGenomics, Inc. | $17.37 | +29.63% | +47.70% | +145.34% |
| NBTX | Nanobiotix S.A. | $44.50 | +17.66% | +101.08% | +394.99% |
| CLOV | Clover Health Investments, Corp. | $4.25 | −1.96% | +76.35% | +57.99% |
| MSB.AX | Mesoblast Limited | 2.45 AUD | +19.85% | −11.73% | +1.03% |
| ADUS | Addus HomeCare Corporation | $120.71 | +1.25% | +13.26% | +4.50% |
| URGN | UroGen Pharma Ltd. | $45.94 | +12.38% | +102.29% | +135.11% |
| MESO | Mesoblast Limited | $16.84 | +16.54% | −7.27% | +4.47% |
| PVLA | Palvella Therapeutics, Inc. | $154.33 | +8.04% | +53.90% | +173.39% |
| AUPH | Aurinia Pharmaceuticals Inc. | $16.54 | +10.56% | +7.75% | +36.58% |
| MD | Pediatrix Medical Group, Inc. | $26.95 | +0.34% | +26.59% | +56.87% |
| 302440.KS | SK bioscience Co.,Ltd. | 38,100.00 KRW | +17.23% | −20.62% | −20.29% |
| XRAY | DENTSPLY SIRONA Inc. | $10.93 | −18.98% | −3.02% | −21.61% |
| EXE.TO | Extendicare Inc. | 31.68 CAD | −17.40% | +51.30% | +146.56% |
| VCEL | Vericel Corporation | $42.44 | −9.14% | +19.18% | +18.25% |
| 9987.T | Suzuken Co., Ltd. | 5,048.00 JPY | −6.26% | −18.11% | −12.93% |
| HCM.L | HUTCHMED (China) Limited | 179.00 GBP | +3.17% | −12.25% | −18.08% |
| ADMA | ADMA Biologics, Inc. | $9.63 | +9.56% | −46.14% | −44.17% |
| ZBIO | Zenas BioPharma, Inc. | $33.04 | +2.32% | −4.23% | +97.73% |
| ESTA | Establishment Labs Holdings Inc. | $72.45 | −21.16% | +5.24% | +70.71% |
| CLOV34.SA | Clover Health Investments, Corp. | 20.84 BRL | −7.01% | +57.16% | +45.23% |
| HCM | HUTCHMED (China) Limited | $12.35 | +10.27% | −9.52% | −17.45% |
| STOK | Stoke Therapeutics, Inc. | $33.09 | +12.59% | +7.09% | +71.45% |
| GN.CO | GN Store Nord A/S | 94.54 DKK | −2.03% | −13.98% | −18.50% |
| 008930.KS | Hanmi Science Co., Ltd. | 43,400.00 KRW | +29.36% | +19.84% | +2.80% |
| NVCR | NovoCure Limited | $17.89 | +9.69% | +36.36% | +50.21% |
| ALIF-B.ST | AddLife AB (publ) | 162.30 SEK | +0.87% | +8.17% | −7.20% |
| GNS.L | Genus plc | 2,298.00 GBP | +3.23% | −9.70% | −12.94% |
| GENB | Generate Biomedicines, Inc. | $16.14 | +22.83% | +27.59% | +27.59% |
| SRPT | Sarepta Therapeutics, Inc. | $19.46 | +26.12% | −8.68% | +7.69% |
| NANO.PA | Nanobiotix S.A. | 35.74 EUR | +8.43% | +88.11% | +358.21% |
| SEM | Select Medical Holdings Corp | $16.51 | −0.12% | +12.30% | +28.14% |
| AGIO | Agios Pharmaceuticals, Inc. Common Stock | $33.99 | −5.56% | +25.06% | −13.45% |
| CMPS | COMPASS Pathways plc | $14.61 | +34.65% | +123.05% | +209.53% |
| 6960.T | Fukuda Denshi Co., Ltd. | 11,970.00 JPY | +5.37% | +57.28% | +79.12% |
| KLRS | Kalaris Therapeutics, Inc. | $4.08 | +22.16% | −50.84% | +32.47% |
| 4BB.L | 4basebio PLC | 470.00 GBP | −10.48% | −23.58% | −46.89% |
| CGTX | Cognition Therapeutics, Inc. | $1.05 | +13.64% | −28.57% | −65.69% |
| PARK | Park Dental Partners, Inc. | $20.85 | +13.81% | +40.88% | +103.41% |
| ABNX.PA | ABIONYX Pharma SA | 1.97 EUR | +5.79% | −49.58% | −31.34% |
| 88Q.DE | 4basebio PLC | 5.35 EUR | −3.60% | −20.15% | −45.69% |
| NANOFH.HE | Nanoform Finland Oyj | 0.96 EUR | +9.34% | −18.64% | +15.66% |
| ILA.AX | Island Pharmaceuticals Limited | 0.45 AUD | +18.42% | +3.45% | +109.30% |
| FBIO | Fortress Biotech, Inc. | $2.81 | −17.11% | −30.27% | +20.09% |
| PLYX | Polaryx Therapeutics, Inc. | $2.09 | +5.03% | −94.03% | −94.03% |
| 004080.KS | Shinhung Co., Ltd | 14,080.00 KRW | +0.28% | +0.57% | +2.54% |
| ATRA | Atara Biotherapeutics, Inc. | $9.38 | +20.10% | −47.21% | −24.05% |
| ADOC.PA | Adocia SA | 4.01 EUR | −0.20% | −40.42% | −54.33% |
| NANOFS.ST | Nanoform Finland Oyj | 10.94 SEK | +15.40% | −15.06% | +19.56% |
| ALDX | Aldeyra Therapeutics, Inc. | $1.56 | −1.27% | −66.60% | −73.33% |
| ACRV | Acrivon Therapeutics, Inc. | $2.08 | +35.06% | −15.45% | +52.94% |
| BIOPOR.CO | BioPorto A/S | 1.24 DKK | +2.48% | +19.00% | −3.13% |
| ECOR | electroCore, Inc. | $10.35 | +69.95% | +127.47% | +86.49% |
| 4579.T | RaQualia Pharma Inc. | 568.00 JPY | +25.39% | −41.56% | +3.46% |
| ALC.AX | Alcidion Group Limited | 0.10 AUD | +10.47% | −5.00% | −5.00% |
| PAR.AX | Paradigm Biopharmaceuticals Limited | 0.22 AUD | +30.30% | −36.76% | −24.56% |
| HYPR | Hyperfine, Inc. | $0.87 | −5.23% | −10.41% | −29.99% |
| IBT-B.ST | Infant Bacterial Therapeutics AB (publ) | 68.60 SEK | +3.94% | +37.75% | +15.88% |
| 214390.KS | Kyongbo Pharmaceutical Co., Ltd | 5,300.00 KRW | +6.11% | −7.02% | +9.78% |
| VISTN.OL | Vistin Pharma ASA | 19.15 NOK | −5.67% | −1.74% | −15.42% |
| 4978.T | ReproCELL Incorporated | 149.00 JPY | +20.16% | +2.05% | −16.29% |
| 4350.T | Medical System Network Co., Ltd. | 497.00 JPY | +1.43% | −2.79% | +7.57% |
| ICCC | ImmuCell Corporation | $10.02 | −10.85% | +69.26% | +64.26% |
| QUAL3.SA | Qualicorp Consultoria e Corretora de Seguros S.A. | 1.64 BRL | +13.10% | −29.00% | −11.35% |
| EAH.L | ECO Animal Health Group plc | 99.00 GBP | +1.54% | −6.60% | +34.69% |
| RLYB | Rallybio Corporation | $16.88 | +4.49% | +198.44% | +257.63% |
| 3417.T | Ohki Healthcare Holdings Co.,Ltd. | 1,039.00 JPY | −2.17% | −25.27% | −21.40% |
| 7V0.DE | Novogenia AG | 6.40 EUR | +7.56% | −16.34% | −25.00% |
| OSE.PA | OSE Immunotherapeutics SA | 3.21 EUR | −0.19% | −39.40% | −47.94% |
| 194A.T | WOLVES HAND CO LTD | 1,877.00 JPY | +48.73% | +8.18% | +102.92% |
| 6678.T | Techno Medica Co., Ltd. | 2,112.00 JPY | +3.63% | −0.76% | +12.34% |
| CWEB.TO | Charlotte's Web Holdings, Inc. | 0.46 CAD | +39.39% | −17.86% | +253.85% |
| 002390.KS | HANDOK Inc. | 9,430.00 KRW | +8.64% | −14.73% | −19.05% |
| NANEXA.ST | Nanexa AB (publ) | 4.63 SEK | +14.46% | +15.03% | +100.43% |
| EQL.ST | EQL Pharma AB (publ) | 27.05 SEK | +34.58% | −54.31% | −67.01% |
| AALR3.SA | Alliança Saúde e Participações S.A. | 2.96 BRL | −8.36% | −36.34% | −52.03% |
| CVRX | CVRx, Inc. | $3.27 | −33.94% | −53.94% | −56.75% |
| ATHE | Alterity Therapeutics Limited | $4.78 | +4.60% | +51.27% | −4.40% |
| ALZCUR.ST | AlzeCure Pharma AB (publ) | 6.40 SEK | +4.23% | +220.80% | +78.27% |
| BB1.AX | BLINKLAB FPO [BB1] | 0.80 AUD | +23.26% | −3.64% | +47.22% |
| 001360.KS | SAMSUNG PHARM. Co., LTD. | 1,270.00 KRW | +7.17% | −18.06% | −21.26% |
| CREO.L | Creo Medical Group PLC | 12.88 GBP | −5.50% | +26.85% | −1.90% |
| CING | Cingulate Inc. | $5.40 | +19.21% | +23.29% | +29.19% |
| 4574.T | Taiko Pharmaceutical Co.,Ltd. | 266.00 JPY | +4.31% | −11.63% | −11.80% |
| GOSS | Gossamer Bio, Inc. | $0.17 | −15.17% | −93.96% | −92.93% |
| 7792.T | Colan Totte.Co.,Ltd. | 1,484.00 JPY | +2.91% | +0.61% | +6.32% |
| MAIA | MAIA Biotechnology, Inc. | $1.39 | +12.10% | −13.13% | −15.76% |
| VRCA | Verrica Pharmaceuticals Inc. | $4.91 | −9.07% | −40.84% | −13.25% |
| DH | Definitive Healthcare Corp. | $0.79 | +11.75% | −66.73% | −80.44% |
| ACET | Adicet Bio, Inc. | $8.95 | +9.15% | +1.47% | −26.01% |
| RPID | Rapid Micro Biosystems, Inc. | $1.67 | −18.93% | −46.82% | −34.77% |
| CTOR | Citius Oncology, Inc. | $0.79 | +45.49% | −27.12% | −62.34% |
| GANX | Gain Therapeutics, Inc. | $1.81 | +4.62% | −43.08% | −2.69% |
| SERA | Sera Prognostics, Inc. | $2.09 | +2.96% | −30.33% | −26.41% |
| POLB.L | Poolbeg Pharma PLC | 8.60 GBP | +36.51% | +120.51% | +164.62% |
| RCE.AX | Recce Pharmaceuticals Ltd | 0.38 AUD | +2.74% | −43.82% | −10.71% |
| 002620.KS | Jeil Pharma Holdings Inc | 7,320.00 KRW | +5.63% | −10.18% | −16.20% |
| HIGH.DE | Cantourage Group SE | 6.00 EUR | +5.63% | +80.72% | +51.90% |
| HLS.TO | HLS Therapeutics Inc. | 3.65 CAD | −13.30% | −24.74% | −30.48% |
| OKYO | OKYO Pharma Limited | $1.55 | −5.49% | −30.49% | −31.42% |
| OMDA.OL | Omda AS | 36.00 NOK | −2.17% | −24.61% | −23.98% |
| OBI.L | Ondine Biomedical Inc. | 11.75 GBP | −14.55% | +34.29% | −24.19% |
| INIFY.OL | INIFY Laboratories AB | 7.95 NOK | −3.05% | +65.63% | +44.55% |
| NXTMH.HE | Nexstim Plc | 9.28 EUR | −4.03% | −33.71% | −26.64% |
| ATH.AX | Alterity Therapeutics Limited | 0.52 AUD | +0.98% | +14.44% | −14.17% |
| TELO | Telomir Pharmaceuticals, Inc. | $1.17 | −0.85% | −12.69% | −20.95% |
| AB.PA | AB Science S.A. | 0.74 EUR | +32.68% | −49.38% | −38.62% |
| 4888.T | Stella Pharma Corporation | 353.00 JPY | +18.06% | +66.51% | −11.75% |
| OM | Outset Medical, Inc. | $4.25 | −9.96% | +14.86% | −69.56% |
| ELTX | Elicio Therapeutics, Inc. | $2.98 | +1.02% | −62.98% | −71.29% |
| DICOT.ST | Dicot Pharma AB | 0.21 SEK | +13.89% | −32.06% | −76.06% |
| 7775.T | Daiken Medical Co., Ltd. | 427.00 JPY | +0.47% | −2.15% | −2.84% |
| MDG.WA | Medicalgorithmics S.A. | 28.85 PLN | +15.40% | −15.89% | −20.30% |
| APLM | Apollomics, Inc. | $26.20 | +43.80% | +35.75% | +320.55% |
| OSTX | OS Therapies Incorporated | $1.65 | +10.00% | +23.13% | −34.00% |
| CRDF | Cardiff Oncology, Inc. | $0.98 | +20.01% | −63.00% | −54.65% |
| ANVS | Annovis Bio, Inc. | $1.78 | +5.33% | −51.23% | −24.26% |
| LONA | LeonaBio, Inc. | $7.81 | +12.05% | +12.21% | +95.25% |
| 7097.T | SAKURASAKU PLUS,Co.,Ltd. | 2,751.00 JPY | −7.53% | −14.84% | −0.99% |
| NRXS | NeurAxis, Inc. | $5.96 | −8.73% | +33.63% | +146.28% |
| PLRX | Pliant Therapeutics, Inc. | $1.16 | +8.41% | −7.20% | −31.36% |
| MNOV | MediciNova, Inc. | $1.48 | +11.28% | +11.28% | +10.45% |
| MDXH | MDxHealth SA | $0.76 | +83.97% | −77.96% | −84.51% |
| KOO.L | Kooth plc | 146.00 GBP | −3.63% | +26.96% | −7.59% |
| STX.L | Shield Therapeutics plc | 4.85 GBP | −15.65% | −50.76% | −37.42% |
| FBIOP | Fortress Biotech, Inc. | $18.40 | −1.92% | +81.10% | +131.74% |
| 4596.T | Kubota Pharmaceutical Holdings Co., Ltd. | 69.00 JPY | +21.05% | +64.29% | +35.29% |
| ALTHX.PA | THX Pharma Société Anonyme | 4.18 EUR | +5.16% | +83.92% | +73.96% |
| SPRO | Spero Therapeutics, Inc. | $1.22 | +2.09% | −48.09% | −38.38% |
| 4875.T | MediciNova, Inc. | 229.00 JPY | +9.57% | +8.53% | +11.17% |
| IBIO | iBio, Inc. | $1.43 | +2.88% | −29.21% | +76.54% |
| ZTEK | Zentek Ltd. | $0.56 | +1.82% | −16.42% | −17.65% |
| 7702.T | JMS Co.,Ltd. | 459.00 JPY | +1.32% | +5.64% | +6.20% |
| XBIT | XBiotech Inc. | $2.31 | +1.76% | −2.94% | −33.62% |
| ZLNA.OL | Zelluna ASA | 21.70 NOK | −2.25% | +55.00% | +56.57% |
| PMVP | PMV Pharmaceuticals, Inc. | $1.31 | +19.09% | +6.50% | −7.75% |
| EXOZ | eXoZymes, Inc. | $7.53 | +71.02% | −31.53% | −22.42% |
| RNTX | Rein Therapeutics Inc. | $0.80 | +2.30% | −36.00% | −27.27% |
| DRIO | DarioHealth Corp. | $7.03 | −6.20% | −33.17% | −26.92% |
| 9341.T | GENOVA, Inc. | 634.00 JPY | −0.94% | +13.48% | +1.56% |
| NNOX | Nano-X Imaging Ltd. | $0.88 | −0.25% | −69.05% | −77.77% |
| CSBR | Champions Oncology, Inc. | $4.92 | −11.03% | −26.13% | −25.45% |
| ONCO.ST | Oncopeptides AB (publ) | 1.65 SEK | +2.93% | −66.11% | −67.92% |
| RNXT | RenovoRx, Inc. | $1.49 | +64.28% | +78.44% | +61.08% |
| LDX.AX | Lumos Diagnostics Holdings Limited | 0.10 AUD | 0.00% | −68.75% | −25.93% |
| HYFT | MindWalk Holdings Corp. | $1.43 | +5.15% | −29.21% | −46.04% |
| SER | Serina Therapeutics, Inc. | $2.63 | +27.05% | +26.56% | −47.29% |
| AVE.AX | Avecho Biotechnology Limited | 0.02 AUD | +20.00% | +152.63% | +300.00% |
| BOLD | Boundless Bio, Inc. | $2.92 | +18.02% | +138.93% | +155.70% |
| GENT.OL | Gentian Diagnostics ASA | 39.00 NOK | 0.00% | −30.89% | −30.41% |
| MAAT.PA | MaaT Pharma SA | 3.04 EUR | +8.96% | −45.52% | −33.91% |
| 2934.T | J Frontier Co.,Ltd. | 1,944.00 JPY | +7.11% | +47.61% | −2.11% |
| TLPH | Talphera, Inc. | $1.26 | −3.08% | +8.62% | +133.33% |
| LYTIX.OL | Lytix Biopharma ASA | 7.78 NOK | −11.59% | −22.04% | −4.19% |
| LTP.AX | LTR PHARMA FPO [LTP] | 0.48 AUD | +5.49% | −32.39% | −4.95% |
| AJ91.DE | DocCheck AG | 10.90 EUR | −6.03% | −13.49% | −9.92% |
| HEALTH.HE | Nightingale Health Oyj | 0.93 EUR | +9.95% | −55.38% | −57.24% |
| R0L.F | J Frontier Co.,Ltd. | 10.30 EUR | +10.75% | −44.02% | −44.02% |
| 4570.T | Immuno-Biological Laboratories Co., Ltd. | 1,145.00 JPY | +25.69% | −41.75% | +140.06% |
| ALGAE.PA | Fermentalg SA | 0.46 EUR | −5.46% | +6.62% | −10.00% |
| 3079.T | DVx Inc. | 931.00 JPY | −2.10% | −18.29% | −7.30% |
| IMA | ImageneBio, Inc. | $5.43 | −5.73% | −19.67% | −60.19% |
| SEZI.ST | Senzime AB (publ) | 3.78 SEK | +3.28% | −30.35% | −39.98% |
| MYO | Myomo, Inc. | $1.53 | +60.21% | +54.55% | +36.61% |
| AHC.AX | Austco Healthcare Limited | 0.22 AUD | −1.12% | −45.68% | −37.14% |
| DMVF3.SA | d1000 Varejo Farma Participações S.A. | 6.15 BRL | −1.44% | −5.38% | +29.47% |
| INKT | MiNK Therapeutics, Inc. | $11.79 | +11.86% | +6.03% | −26.22% |
| HVO.L | hVIVO plc | 6.50 GBP | −10.34% | +1.56% | −35.00% |
| 9265.T | Yamashita Health Care Holdings,Inc. | 3,745.00 JPY | +7.61% | +16.27% | +24.40% |
| XLO | Xilio Therapeutics, Inc. | $9.05 | −1.09% | −3.81% | −5.63% |
| HRTX | Heron Therapeutics, Inc. | $0.31 | −36.29% | −75.22% | −77.04% |
| V3V.DE | FamiCord AG | 2.86 EUR | +0.70% | −52.73% | −61.35% |
| DXR | Daxor Corporation | $10.03 | −5.87% | −30.19% | −11.60% |
| 7133.T | HYUGA PRIMARY CARE Co.,Ltd. | 1,300.00 JPY | +5.95% | +15.08% | −0.72% |
| 4524.T | Morishita Jintan Co., Ltd. | 2,241.00 JPY | +0.86% | +4.83% | +4.22% |
| 3446.T | JTEC Corporation | 1,553.00 JPY | +7.62% | +27.30% | +32.62% |
| 7776.T | CellSeed Inc. | 232.00 JPY | +15.42% | −16.85% | −47.39% |
| COCH | Envoy Medical, Inc. | $0.74 | +8.39% | +5.75% | −37.09% |
| 4896.T | K Pharma,Inc. | 763.00 JPY | +6.71% | +13.88% | +14.56% |
| SCYX | SCYNEXIS, Inc. | $5.67 | +56.20% | +787.32% | +579.04% |
| 4564.T | OncoTherapy Science, Inc. | 21.00 JPY | +5.00% | 0.00% | −25.00% |
| IMMP | Immutep Limited | $0.38 | −2.56% | −87.12% | −77.11% |
| 063160.KS | CKD Bio Corp. | 14,080.00 KRW | +15.41% | −30.81% | −38.38% |
| ALTHE.PA | Theraclion SA | 0.63 EUR | +6.55% | +3.93% | −22.30% |
| 7963.T | Koken Ltd. | 1,817.00 JPY | +1.96% | −1.52% | +3.90% |
| ALSMA.PA | S.M.A.I.O S.A. | 7.60 EUR | −2.56% | +23.58% | +14.29% |
| ALKLH.PA | Klea Holding SA | 0.15 EUR | −4.73% | −31.24% | −32.00% |
| NTRB | Nutriband Inc. | $4.50 | +52.28% | +1.58% | −29.80% |
| 4571.T | Nano Holdings, Inc. | 103.00 JPY | +8.42% | −27.46% | −31.79% |
| BVC.L | BATM Advanced Communications Ltd. | 12.30 GBP | −3.91% | −23.36% | −21.90% |
| HEMO.L | Hemogenyx Pharmaceuticals Plc | 588.00 GBP | −8.12% | +3.52% | +70.43% |
| GNTA | Genenta Science S.p.A. | $1.13 | −28.03% | −19.86% | −70.07% |
| 000230.KS | Ildong Holdings Co., Ltd. | 6,420.00 KRW | +13.43% | −51.27% | −29.17% |
| ATX.AX | Amplia Therapeutics Limited | 0.15 AUD | +11.54% | −14.71% | −14.71% |
| SRTS | Sensus Healthcare, Inc. | $3.29 | +11.90% | −19.76% | +3.46% |
| ATYR | aTyr Pharma, Inc. | $0.55 | +11.54% | −27.40% | −89.34% |
| IMM.AX | Immutep Limited | 0.05 AUD | +8.51% | −88.14% | −79.18% |
| ALA.AX | Arovella Therapeutics Limited | 0.06 AUD | −1.59% | −33.33% | −30.34% |
| EPIS-B.ST | Episurf Medical AB (publ) | 0.08 SEK | +37.70% | +90.12% | +71.52% |
| 4572.T | Carna Biosciences, Inc. | 402.00 JPY | +37.67% | 0.00% | +81.90% |
| MOB.ST | Moberg Pharma AB (publ) | 10.70 SEK | +9.52% | +4.49% | +32.92% |
| FLUO.ST | FluoGuide A/S | 33.40 SEK | +6.71% | −9.49% | −18.34% |
| TIL | Instil Bio, Inc. | $7.83 | +7.41% | −30.52% | −72.04% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | 14.35 SEK | −8.89% | −24.47% | −46.25% |
| TELY.TO | TelyRx Holdings Inc. | 2.75 CAD | −1.79% | −21.43% | −21.43% |
| HYPD | Hyperion DeFi, Inc. | $3.39 | +40.08% | −5.31% | −50.87% |
| BTMD | biote Corp. | $1.55 | −30.80% | −37.25% | −53.87% |
| MODU.HE | Modulight Oyj | 1.07 EUR | −0.47% | −7.87% | −19.92% |
| MDAI | Spectral AI, Inc. | $1.61 | +3.21% | +11.03% | −23.33% |
| 9218.T | Mental Health Technologies Co.,Ltd. | 778.00 JPY | +5.14% | −4.31% | −7.41% |
| 4597.T | Solasia Pharma K.K. | 30.00 JPY | +3.45% | +7.14% | −18.92% |
| CANTA.ST | Cantargia AB (publ) | 1.91 SEK | +3.24% | −53.64% | −27.38% |
| 002720.KS | Kukje Pharma Co., Ltd. | 3,330.00 KRW | +7.77% | −22.89% | −29.09% |
| TCRX | TScan Therapeutics, Inc. | $0.78 | +0.44% | −23.78% | −58.43% |
| SVS.MI | Svas Biosana S.p.A. | 8.24 EUR | −5.07% | +3.00% | +0.98% |
| PTX.AX | Prescient Therapeutics Limited | 0.07 AUD | −17.28% | −19.28% | +63.41% |
| M3V.DE | MeVis Medical Solutions AG | 23.80 EUR | +2.59% | +0.39% | −0.42% |
| 004720.KS | PharmGen Science, Inc. | 3,160.00 KRW | −0.94% | −28.18% | −29.31% |
| HRTIS.HE | Herantis Pharma Oyj | 1.69 EUR | +6.42% | −26.20% | −2.31% |
| AIFORIA.HE | Aiforia Technologies Oyj | 1.17 EUR | +2.99% | −52.44% | −60.34% |
| IBO | Impact BioMedical Inc. | $0.44 | +2.35% | −15.20% | −24.12% |
| 8769.T | Advantage Risk Management Co., Ltd. | 499.00 JPY | −4.04% | −16.03% | −12.77% |
| COIL.L | Coiled Therapeutics plc | 9.50 GBP | −9.52% | −20.83% | −26.92% |
| ORX.ST | Orexo AB (publ) | 13.54 SEK | −5.71% | −58.27% | −35.06% |
| 7096.T | StemCell Institute Inc. | 762.00 JPY | +6.87% | −3.30% | −22.80% |
| NSRX | Nasus Pharma Ltd. | $4.05 | +33.66% | −46.36% | −49.75% |
| MLSS | Milestone Scientific Inc. | $0.54 | +25.44% | +86.00% | −10.10% |
| MCRB | Seres Therapeutics, Inc. | $4.76 | −0.83% | −68.58% | −74.79% |
| EDSA | Edesa Biotech, Inc. | $4.94 | −0.60% | +229.33% | +105.83% |
| POCI | Precision Optics Corporation, Inc. | $4.35 | −2.03% | +2.35% | −12.30% |
| SVE.WA | Synthaverse S.A. | 3.06 PLN | +9.29% | −20.21% | −36.25% |
| 3628.T | Data Horizon Co.,Ltd. | 592.00 JPY | −0.84% | +19.60% | +7.64% |
| 4890.T | Tsubota Laboratory Incorporated | 289.00 JPY | +20.42% | −11.62% | −21.25% |
| PHX.AX | PharmX Technologies Limited | 0.10 AUD | −5.00% | −36.67% | −17.39% |
| M7T.AX | Mach7 Technologies Limited | 0.28 AUD | −6.67% | −58.52% | −13.85% |
| CYC.AX | Cyclopharm Limited | 0.52 AUD | −13.11% | −47.51% | −48.30% |
| ALGS | Aligos Therapeutics, Inc. | $7.51 | +76.71% | −17.74% | −33.72% |
| 3671.T | Softmax Co., Ltd | 310.00 JPY | −4.32% | −9.36% | −7.87% |
| BIOBV.HE | Biohit Oyj | 2.60 EUR | −6.14% | −27.78% | −8.13% |
| QTI | QT Imaging Holdings, Inc. | $3.17 | +19.62% | −46.72% | −91.44% |
| GRCE | Grace Therapeutics, Inc. | $2.15 | −4.44% | −41.26% | −29.97% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | 53.00 JPY | +15.22% | +8.16% | −39.08% |
| IMMU.ST | Mendus AB (publ) | 7.10 SEK | +2.60% | +23.05% | −4.57% |
| MGX | Metagenomi Therapeutics, Inc. | $1.22 | +0.83% | −26.95% | −34.41% |
| 2370.T | MEDINET Co., Ltd. | 26.00 JPY | 0.00% | −10.34% | −33.33% |
| FLNA | Filana Therapeutics, Inc. | $0.92 | +5.05% | −55.77% | −59.98% |
| AIAI.TO | NetraMark Holdings Inc. | 0.67 CAD | −14.10% | −39.09% | −60.82% |
| CLBIO.ST | Corline Biomedical AB | 18.85 SEK | +6.80% | +8.96% | +45.56% |
| ABLD.PA | ABL Diagnostics Société anonyme | 2.40 EUR | −2.44% | −37.50% | −46.67% |
| OSSD.ST | OssDsign AB (publ) | 4.00 SEK | −10.01% | −64.60% | −73.26% |
| IXHL | Incannex Healthcare Inc. | $3.70 | +25.00% | −68.38% | −81.59% |
| ENZY.ST | Enzymatica AB (publ) | 1.90 SEK | +4.97% | −1.04% | −20.17% |
| 3386.T | Cosmo Bio Company,Limited | 1,241.00 JPY | −1.19% | −4.83% | +7.72% |
| MREO | Mereo BioPharma Group plc | $0.28 | −10.03% | −45.49% | −84.20% |
| 6059.T | UCHIYAMA HOLDINGS Co.,Ltd. | 363.00 JPY | +4.31% | −1.62% | +14.24% |
| ELUT | Elutia Inc. | $1.00 | +9.29% | +55.52% | −54.75% |
| MPAL.L | MedPal AI PLC | 3.75 GBP | +22.95% | −25.00% | −40.00% |
| 9340.T | ASO International, Inc. | 714.00 JPY | +0.28% | −1.79% | +0.18% |
| NEPH | Nephros, Inc. | $4.05 | +15.71% | −14.74% | 0.00% |
| CTE.AX | Cryosite Limited | 1.25 AUD | +4.17% | +25.00% | +56.25% |
| ONCIN.OL | Oncoinvent ASA | 85.00 NOK | −2.07% | +80.85% | +10.90% |
| TVGN | Tevogen Inc. | $6.70 | +19.86% | −63.19% | −85.43% |
| 3750.T | ADR Biomedical Holdings Inc. | 785.00 JPY | +0.26% | −8.08% | −14.11% |
| 4880.T | CellSource Co., Ltd. | 345.00 JPY | +9.87% | −13.75% | −42.78% |
| ALCOX.PA | Nicox S.A. | 0.38 EUR | +0.79% | +21.76% | +2.70% |
| ALNOV.PA | Novacyt S.A. | 0.51 EUR | +16.21% | +21.19% | +7.38% |
| 000220.KS | Yuyu Pharma, Inc. | 3,750.00 KRW | +9.17% | −18.30% | −11.87% |
| PAVM | PAVmed Inc. | $5.32 | −1.12% | −27.42% | −63.21% |
| VVEO3.SA | CM Hospitalar S/A | 0.67 BRL | −1.47% | −50.37% | −24.72% |
| NCYT.L | Novacyt S.A. | 43.50 GBP | +17.73% | +21.00% | +7.81% |
| OPTOMED.HE | Optomed Oyj | 1.71 EUR | +6.36% | −54.99% | −54.39% |
| SNWV | SANUWAVE Health, Inc. | $4.87 | −23.43% | −83.14% | −89.02% |
| NSPR | InspireMD, Inc. | $0.89 | +30.88% | −52.15% | −63.52% |
| PMED.MI | PiùMedical S.p.A. | 5.60 EUR | −4.27% | −6.67% | −3.55% |
| BOT.AX | Botanix Pharmaceuticals Limited | 0.02 AUD | +5.26% | −85.19% | −86.67% |
| MOC.WA | Molecure S.A. | 6.03 PLN | −2.58% | −8.08% | −22.39% |
| SHG.AX | Singular Health Group Ltd | 0.18 AUD | −12.50% | −33.96% | −46.15% |
| LGP.AX | Little Green Pharma Ltd | 0.07 AUD | −12.82% | −47.69% | −43.33% |
| 4893.T | Noile-Immune Biotech Inc. | 148.00 JPY | +11.28% | +10.45% | −16.38% |
| CRVO | CervoMed Inc. | $2.65 | +3.52% | −65.98% | −71.78% |
| MNTC.ST | Mentice AB (publ) | 12.75 SEK | −13.85% | −4.85% | −6.59% |
| CNTX | Context Therapeutics Inc. | $0.42 | −28.31% | −72.66% | −50.73% |
| 206A.T | PRISM BioLab Co.,LTD | 170.00 JPY | +18.06% | +5.59% | −5.56% |
| 002630.KS | ORIENT BIO Inc. | 919.00 KRW | +4.31% | +49.19% | +49.67% |
| DCGO | DocGo Inc. | $0.40 | −37.37% | −55.50% | −75.60% |
| 7079.T | WDB coco Co., Ltd. | 2,581.00 JPY | −0.77% | −1.74% | −3.52% |
| PKY.AX | Pathkey.AI Ltd | 0.04 AUD | +44.44% | +143.75% | +77.27% |
| PETS | PetMed Express, Inc. | $1.79 | −10.95% | −45.76% | −43.35% |
| CPHI | China Pharma Holdings, Inc. | $0.90 | −30.84% | −25.69% | −35.78% |
| IVACC.ST | Intervacc AB (publ) | 1.10 SEK | −14.11% | +17.98% | +4.78% |
| 7980.T | Shigematsu Works Co., Ltd. | 855.00 JPY | +3.51% | +10.49% | +6.69% |
| SNT.AX | Syntara Limited | 0.03 AUD | +22.73% | −20.59% | +1.89% |
| ORT-B.ST | Ortoma AB (publ) | 7.80 SEK | −13.24% | −42.22% | −66.52% |
| BDMD | Baird Medical Investment Holdings Limited | $1.18 | +10.28% | −11.94% | −52.03% |
| MVP.AX | Medical Developments International Limited | 0.47 AUD | +2.20% | −15.45% | −19.83% |
| NAVA.OL | Navamedic ASA | 14.90 NOK | −8.31% | −35.22% | −32.27% |
| 7707.T | Precision System Science Co., Ltd. | 218.00 JPY | +10.10% | +14.74% | +6.34% |
| 7681.T | LEOCLAN Co.,Ltd. | 999.00 JPY | +4.61% | −2.15% | −10.99% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.